Citation Impact

Citing Papers

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Diastolic dysfunction as a cause of heart failure
1993
Cigarette Smoking Increases Endothelial-Derived Vasorelaxation in the Rat Carotid Artery in a Dose-Dependent Manner
1997 StandoutNobel
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
2006
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome
2000
Doppler Echocardiographic Assessment of Progression of Aortic Regurgitation
1997
Reduced Systemic Arterial Compliance Impacts Significantly on Left Ventricular Afterload and Function in Aortic Stenosis
2005
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Normal left ventricular mechanical function and synchrony values by speckle-tracking echocardiography in the transplanted heart with normal ejection fraction
2010
The Failing Heart — An Engine Out of Fuel
2007 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
1993
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082)
1993
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Raynaud's phenomenon
1997
Uric Acid and Cardiovascular Risk
2008 Standout
Features and predictors of ascending aortic dilatation in association with a congenital bicuspid aortic valve
2003
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Diagnostic and Prognostic Value of Myocardial Scintigraphy With Thallium-201 and Gallium-67 in Cardiac Sarcoidosis
1995
CHRONIC AORTIC REGURGITATION
1998
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Sarcoidosis of the Heart
1993
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
1993 StandoutNature
Angiogenesis in health and disease
2003 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
1990
Sarcoidosis
2013 Standout
Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis
2012
Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats
2007
Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis
2020
Rescue of Diabetes-Related Impairment of Angiogenesis by Intramuscular Gene Therapy with Adeno-VEGF
1999
Acute Effects of Passive Smoking on the Coronary Circulation in Healthy Young Adults
2001
A simplified method for determining regurgitant fraction by Doppler echocardiography in patients with aortic regurtitation
1994
Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation
1993
Cigarette smoking increases the development of intimal hyperplasia after vascular injury
1996
Diabetes and Atherosclerosis
2002 Standout
Zidovudine in Patients with Human Immunodeficiency Virus (HIV) Infection and Kaposi Sarcoma
1989
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.
1998
Burden of valvular heart diseases: a population-based study
2006 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
The spectrum of diseases of small coronery arteries and their physiologic consequences
1990
Endothelial dysfunction in diabetes
2000
Sarcoidosis
1997 Standout
Non-adherence to cardiovascular medications
2014
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Reduction of Maximal Oxygen Uptake in Sarcoidosis: Relationship with Disease Severity
2011
Association of carotid atherosclerosis and left ventricular hypertrophy
1995
Aging-Associated Endothelial Dysfunction in Humans Is Reversed by L-Arginine
1996
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
Coronary flow reserve as a physiologic measure of stenosis severity
1990
Kaposi's Sarcoma
2000 Standout
Homocysteine and Atherothrombosis
1998 Standout
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes
2007
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
1994 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Role of Poly(ADP-Ribose) Polymerase-1 Activation in the Pathogenesis of Diabetic Complications: Endothelial Dysfunction, as a Common Underlying Theme
2005
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Quantitative Doppler assessment of valvular regurgitation.
1993
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
2000
Fiber‐Based Wearable Electronics: A Review of Materials, Fabrication, Devices, and Applications
2014 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection
1992
Diabetes and Endothelial Dysfunction: A Clinical Perspective
2001
Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase
2001
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Conjugated Estrogens Acutely Abolish Abnormal Cold-Induced Coronary Vasoconstriction in Male Cardiac Allografts
1998
Quantitative evaluation of aortic insufficiency by continuous wave Doppler echocardiography
1986
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
Transport, metabolism and elimination mechanisms of anti-HIV agents
1999
Impact of systemic hypertension on the assessment of aortic stenosis
2005
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography
2003 Standout
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
1996 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Spermidine in health and disease
2018 StandoutScience
Mechanisms and Models in Heart Failure
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Endothelial dysfunction in pulmonary arteries of patients with mild COPD
1998
Maximal Coronary Flow Reserve and Metabolic Coronary Vasodilation in Patients With Diabetes Mellitus
1995
Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance.
1993
Effect of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors on the Progression of Calcific Aortic Stenosis
2001
Metal–Organic Frameworks in Biomedicine
2011 Standout
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
2004
Effects of DNA methylation on topoisomerase I and II cleavage activities.
1994 StandoutNobel
Iron Chelation Suppresses Ferritin Upregulation and Attenuates Vascular Dysfunction in the Aorta of Angiotensin II–Infused Rats
2005
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
End diastolic flow velocity just beneath the aortic isthmus assessed by pulsed Doppler echocardiography: a new predictor of the aortic regurgitant fraction.
1991
Insights From Three-Dimensional Echocardiography Into the Mechanism of Functional Mitral Regurgitation
1997
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart
1996
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Enalapril and Losartan Reduced Cardiac Mass and Improved Coronary Hemodynamics in SHR
1997
Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
2007 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout

Works of A Nitenberg being referenced

Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: A 10 year follow-up study
2005
Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings
1993
Coronary vasodilator reserve in untreated and treated hypertensove patients with and without left ventricular hypertrophy
1993
Coronary artery response to cold-pressor test is impaired early after operation in heart transplant recipients
1995
Coronary vasodilation induced by intracoronary enalaprilat: an argument for the role of a local renin-angiotensin system in patients with dilated cardiomyopathy
1989
Doppler echocardiographic measurement of mitral flow volume: Validation of a new method in adult patients
1988
Postprandial endothelial dysfunction: role of glucose, lipids and insulin
2006
Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis
1988
VENTRICULOARTERIAL COUPLING AND LEFT VENTRICULAR EFFICIENCY IN HEART TRANSPLANT RECIPIENTS
1997
Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries
1988
Epicardial coronary arteries are not adequately sized in hypertensive patients
1996
Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans
2003
Assessment and follow-up of patients with aortic regurgitation by an updated Doppler echocardiographic measurement of the regurgitant fraction in the aortic arch.
1985
Coronary Microvascular Adaptation to Myocardial Metabolic Demand Can Be Restored by Inhibition of Iron-Catalyzed Formation of Oxygen Free Radicals in Type 2 Diabetic Patients
2002
Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.
1988
Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients.
1997
Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function
1993
A rare cause of cyanosis and polycythemia: anomalous systemic venous connections without associated intracardiac malformations
1981
[Vascular endothelium: a target organ for diabetes mellitus].
2002
Cardiac sarcoidosis: Reversion of myocardial perfusion abnormalities by dipyridamole
1985
Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function
1993
[Coronary vasoconstriction induced by acetylcholine in young smokers with normal angiographic coronary vessels].
1993
Coronary Artery Responses to Physiological Stimuli Are Improved by Deferoxamine but not by l -Arginine in Non–Insulin-Dependent Diabetic Patients With Angiographically Normal Coronary Arteries and No Other Risk Factors
1998
Nifedipine and Thallium-201 Myocardial Perfusion in Progressive Systemic Sclerosis
1986
Angiotensin-Converting Enzyme Inhibition Restores Flow-Dependent and Cold Pressor Test–Induced Dilations in Coronary Arteries of Hypertensive Patients
1996
Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy
1985
Decreased coronary reserve in primary scleroderma myocardial disease
1985
Rankless by CCL
2026